Literature DB >> 14679301

Mouse cardiac surgery: comprehensive techniques for the generation of mouse models of human diseases and their application for genomic studies.

Oleg Tarnavski1, Julie R McMullen, Martina Schinke, Qing Nie, Sekwon Kong, Seigo Izumo.   

Abstract

Mouse models mimicking human diseases are important tools in trying to understand the underlying mechanisms of many disease states. Several surgical models have been described that mimic human myocardial infarction (MI) and pressure-overload-induced cardiac hypertrophy. However, there are very few detailed descriptions for performing these surgical techniques in mice. Consequently, the number of laboratories that are proficient in performing cardiac surgical procedures in mice has been limited. Microarray technologies measure the expression of thousands of genes simultaneously, allowing for the identification of genes and pathways that may potentially be involved in the disease process. The statistical analysis of microarray experiments is highly influenced by the amount of variability in the experiment. To keep the number of required independent biological replicates and the associated costs of the study to a minimum, it is critical to minimize experimental variability by optimizing the surgical procedures. The aim of this publication was to provide a detailed description of techniques required to perform mouse cardiac surgery, such that these models can be utilized for genomic studies. A description of three major surgical procedures has been provided: 1) aortic constriction, 2) pulmonary artery banding, 3) MI (including ischemia-reperfusion). Emphasis has been placed on technical procedures with the inclusion of thorough descriptions of all equipment and devices employed in surgery, as well as the application of such techniques for expression profiling studies. The cardiac surgical techniques described have been, and will continue to be, important for elucidating the molecular mechanisms of cardiac hypertrophy and failure with high-throughput technology.

Entities:  

Mesh:

Year:  2004        PMID: 14679301     DOI: 10.1152/physiolgenomics.00041.2003

Source DB:  PubMed          Journal:  Physiol Genomics        ISSN: 1094-8341            Impact factor:   3.107


  137 in total

1.  Toll-like receptor 4 signaling confers cardiac protection against ischemic injury via inducible nitric oxide synthase- and soluble guanylate cyclase-dependent mechanisms.

Authors:  E Wang; Yan Feng; Ming Zhang; Lin Zou; Yan Li; Emmanuel S Buys; Peigen Huang; Peter Brouckaert; Wei Chao
Journal:  Anesthesiology       Date:  2011-03       Impact factor: 7.892

2.  ACE inhibition prevents diastolic Ca2+ overload and loss of myofilament Ca2+ sensitivity after myocardial infarction.

Authors:  S Zalvidea; L André; X Loyer; C Cassan; Y Sainte-Marie; J Thireau; I Sjaastad; C Heymes; J-L Pasquié; O Cazorla; F Aimond; S Richard
Journal:  Curr Mol Med       Date:  2012-02       Impact factor: 2.222

3.  Protein kinase C binding protein 1 inhibits hypoxia-inducible factor-1 in the heart.

Authors:  Kathryn J Schunke; Chad B Walton; David R Veal; Chrisy T Mafnas; Cynthia D Anderson; Allison L Williams; Ralph V Shohet
Journal:  Cardiovasc Res       Date:  2019-07-01       Impact factor: 10.787

4.  Alteration in ventricular pressure stimulates cardiac repair and remodeling.

Authors:  Kazumasa Unno; Angelos Oikonomopoulos; Yusuke Fujikawa; Yusuke Okuno; Singo Narita; Tomohiro Kato; Ryo Hayashida; Kazuhisa Kondo; Rei Shibata; Toyoaki Murohara; Yanfei Yang; Seema Dangwal; Konstantina-Ioanna Sereti; Qiu Yiling; Kory Johnson; Alokkumar Jha; David E Sosnovik; Yang Fann; Ronglih Liao
Journal:  J Mol Cell Cardiol       Date:  2019-06-17       Impact factor: 5.000

5.  Protective effects of exercise and phosphoinositide 3-kinase(p110alpha) signaling in dilated and hypertrophic cardiomyopathy.

Authors:  Julie R McMullen; Fatemeh Amirahmadi; Elizabeth A Woodcock; Martina Schinke-Braun; Russell D Bouwman; Kimberly A Hewitt; Janelle P Mollica; Li Zhang; Yunyu Zhang; Tetsuo Shioi; Antje Buerger; Seigo Izumo; Patrick Y Jay; Garry L Jennings
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-03       Impact factor: 11.205

6.  HIF1 mediates a switch in pyruvate kinase isoforms after myocardial infarction.

Authors:  Allison Lesher Williams; Vedbar Khadka; Mingxin Tang; Abigail Avelar; Kathryn J Schunke; Mark Menor; Ralph V Shohet
Journal:  Physiol Genomics       Date:  2018-04-13       Impact factor: 3.107

7.  Unique mechanistic insights into the beneficial effects of soluble epoxide hydrolase inhibitors in the prevention of cardiac fibrosis.

Authors:  Padmini Sirish; Ning Li; Jun-Yan Liu; Kin Sing Stephen Lee; Sung Hee Hwang; Hong Qiu; Cuifen Zhao; Siu Mei Ma; Javier E López; Bruce D Hammock; Nipavan Chiamvimonvat
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-14       Impact factor: 11.205

Review 8.  Animal models of chronic obstructive pulmonary disease.

Authors:  Joanne L Wright; Manuel Cosio; Andrew Churg
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-05-02       Impact factor: 5.464

9.  Novel role of aminopeptidase-A in angiotensin-(1-7) metabolism post myocardial infarction.

Authors:  Mahmoud S Alghamri; Mariana Morris; J Gary Meszaros; Khalid M Elased; Nadja Grobe
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-01-24       Impact factor: 4.733

10.  Imaging the beating heart in the mouse using intravital microscopy techniques.

Authors:  Claudio Vinegoni; Aaron D Aguirre; Sungon Lee; Ralph Weissleder
Journal:  Nat Protoc       Date:  2015-10-22       Impact factor: 13.491

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.